BRC Therapeutics
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$23M
Company Overview
BRC Therapeutics is a biopharmaceutical company that develops cannabinoid-based prescription medicines for the treatment of pain and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRC Therapeutics Comparables
Compare BRC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Groff North America | 84% | |
| Maridose LLC | 83% | |
| Royal Emerald Pharmaceuticals | 80% |
BRC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 | ||||
| Convertible Debt | Oct 2, 2020 |
BRC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Achari Ventures | Series A |
| Intrinsic Capital Partners | Series A |
| Delta Emerald Ventures | Series A |
| AFI Capital Partners | Series A |
| Argonautic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2025
Dr. Stephen Wright joins as Advisor in Drug Development.
- Oct 4, 2022
$20M round led by Intrinsic Capital Partners.
Recent news
Latest coverage and updates
- attends_eventSep 28, 2026
BRC Therapeutics announced its participation in the Regulatory Perspectives on Herbal Medicinal/Botanical Drug Product Development workshop in the Netherlands on Sep 28th '26
- hiresAug 24, 2026
BRC Therapeutics hired Chandra Ramanathan as Executive Vice President of Commercialization and Strategy on Aug 24th '26.
- attends_eventAug 11, 2026
BRC Therapeutics will attend event Nucleate Global Summit 2026 on Aug 16th '26.
BRC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BRC Therapeutics's valuation, stock price, and market status.
Is BRC Therapeutics a public or private company?
BRC Therapeutics is a private company.
What is the current stock price of BRC Therapeutics?
BRC Therapeutics is a private company with no public stock price. Caplight tracks BRC Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is BRC Therapeutics worth (valuation)?
Valuation information for BRC Therapeutics is not publicly available.
Can I buy BRC Therapeutics stock?
BRC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BRC Therapeutics's last funding round?
BRC Therapeutics's most recent funding round was Series A on October 4, 2022.
Who are the main investors in BRC Therapeutics?
Key investors in BRC Therapeutics include Intrinsic Capital Partners.
Will BRC Therapeutics IPO soon?
No public IPO plans have been announced for BRC Therapeutics.
How can I track BRC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BRC Therapeutics's secondary market activity and sign up for updates.